NetScientific Plc is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential in predominately the UK and USA, as well as globally.
The Group leverages trans-Atlantic relationships and global opportunities to deliver shareholder value. NetScientific looks to maximise shareholder returns through focused execution of its investment strategy with current portfolio companies, and targeted investments in existing and new investments.
NetScientific develops a customized investment and realisation strategy for its portfolio companies by adding value through management, incubation, advisory services and fund-raising support.
The group facilitates the companies it works with, to access the right type of funding, proactive management support and resources specific to their sector, stage of development and available opportunities.

Annual Report and Accounts 2020

NetScientific PLC annual report and accounts for the year ended 31 December 2020

‘2020 was a year of challenge, turnaround, transformation

and good progress for NetScientific PLC’

Watch Out Latest Interviews

NetScientific Present at IMC
Netscientific at MELLO Events
previous arrow
next arrow
NetScientific Present at IMC
Netscientific at MELLO Events
previous arrow
next arrow

Annual Results 2020 from Investor Meet Company Webinar

Results and company update from the annual report and accounts 2020.

If you would like to watch future presentations and haven’t registered yet, sign up to the platform here:

Mello Healthcare Event, May 2021

NetScientific’s CEO, Dr. Ilian Iliev and Chairman, John Clarkson present our latest Investor Presentation at this week’s Mello Events Healthcare Conference.

Our Subsidiaries and Portfolio

A Focus on Life Sciences, Technology, and Sustainability

Board and Management

Sector-specialist senior management team with extensive commercial experience.

Dr Ilian Iliev

Chief Executive Officer

John Clarkson

Executive Chairman

Clive Sparrow

Non-Executive Director

Professor Stephen Smith

Non-Executive Director

Stephen Crowe

Chief Financial Officer


ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated with its brand-new K-POSTN Assay, which the company intends to launch…
ProAxsis, one of NetScientific's portfolio companies specialized in the Life Sciences sector, has just presented its new NEATstik product which has been specially developed to make an immediate…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Phase 2 Clinical Trial Update   PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase…
NetScientific PLC: Life Sciences & Technology Investments